Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TC-6987 in persistent mild to moderate asthma
NCT01296087Phase 2Completed
- Sponsor
- Targacept
- Start
- Feb 2011
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TC-6987 in asthma, sponsored by Targacept. Started Feb 2011; status: completed.
02
Drugs
TC-6987
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01296087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01296087.